Bukof

50 mg

Generic Name: Butamirate Citrate 50 mg

Product Description:

Bukof Tablet (SR) contains Butamirate Citrate, a non-opioid antitussive (cough suppressant) agent. It works centrally by inhibiting the cough reflex, providing relief from dry (non-productive) cough without causing respiratory depression or dependence.

Composition:

• Each sustained-release tablet contains:

  • Butamirate Citrate 50 mg

Indications:

• Symptomatic treatment of dry, irritating, or non-productive cough associated with:

  • Viral respiratory tract infections

  • Postoperative cough

  • Whooping cough

  • Cough of smokers

Dosage & Administration:

• Adults and adolescents over 12 years: 50 mg, 1 tablet twice daily, or as directed by a physician.

• The sustained-release formulation allows for twice-daily dosing.

Mechanism of Action:

Butamirate Citrate acts on the cough center in the brainstem, reducing the urge to cough without affecting respiration.

Contraindications:

• Hypersensitivity to Butamirate Citrate or any component of the formulation.

• Use caution in children under 12 years unless recommended by a physician.

Precautions:

• Not recommended for productive cough where mucus clearance is needed.

• Should be used with caution in patients with a history of severe liver dysfunction.

Adverse Effects:

• Occasionally: Drowsiness, dizziness, nausea, diarrhea, skin rash, and gastrointestinal discomfort.

Storage:

• Store below 30°C, protect from light and moisture.

• Keep out of reach of children.